Home / Health / Bodegas Selling Banned Weight-Loss Drug
Bodegas Selling Banned Weight-Loss Drug
3 Jul
Summary
- Experimental weight-loss drug retatrutide sold in Brooklyn bodegas.
- Vials sold for $95 without prescription or age verification.
- Vendor's lab reports for drug purity appear fraudulent.
Experimental weight-loss drug retatrutide, unapproved by the FDA, is now appearing in New York bodegas, sold alongside everyday items. A CBS News investigation found a Brooklyn store selling vials for $95 without requiring a prescription or age verification, despite labels indicating "not for human consumption."
The drug, developed by Eli Lilly, has shown promise in clinical trials, igniting a significant black market. The vendor, Indr Labs, claims its products are for research only and have high purity, but its provided certificates of analysis appear to be falsified. A third-party lab has denied issuing these reports.
The sale of these research-grade peptides over the counter is considered aggressive and concerning by drug regulation experts. While Eli Lilly urges action against illicit networks, the FDA has struggled to curb the sale of such unproven drugs. Reports of adverse effects and toxicities have also begun to surface.
